Suchergebnisse - "Celio, Luigi"

PubPharm (107)

1

Comment on "Dexamethasone-sparing on days 2-4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin : a randomized phase III trial (SPARED Trial)"

enthalten in: British journal of cancer | 2024

von Celio, L. | Antonuzzo, A. | Aapro, M.

2

Characteristics of nausea and its impact on health-related quality of life in cisplatin-treated patients receiving dexamethasone-sparing prophylaxis : an analysis of the LUNG-NEPA study

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024

von Celio, L. | Aapro, M.

3

Characteristics of nausea and its impact on health-related quality of life in cisplatin-treated patients receiving dexamethasone-sparing prophylaxis: an analysis of the LUNG-NEPA study

enthalten in: Supportive care in cancer | 2024

von Celio, L. | Aapro, M.

4

Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in older patients (>65 years) fit for cisplatin : A sub-analysis from a phase 3 study

enthalten in: Journal of geriatric oncology | 2023

von Celio, L. | Bartsch, R. | Aapro, M.

5

Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)

enthalten in: Scientific reports | 2023

von Celio, L. | Cortinovis, D. | Cogoni, A. | +18

6

Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis : a combined analysis

enthalten in: Future oncology (London, England) | 2022

von Celio, L. | Bonizzoni, E. | Montani, E. | +1

7

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer

enthalten in: Cancers | 2022

von Giaccherini, C. | Verzeroli, C. | Russo, L. | +19

8

Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting : results from a randomized phase 3 study

enthalten in: BMC cancer | 2022

von Celio, L. | Cortinovis, D. | Cogoni, A. | +18

9

Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study

enthalten in: BMC cancer | 2022

von Celio, L. | Cortinovis, D. | Cogoni, A. | +18

10

Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting : From Clinical Trials to Daily Practice

enthalten in: Current cancer drug targets | 2022

von Aapro, M. | Jordan, K. | Scotté, F. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]